Ikena Oncology Stock Price on May 29, 2024
| IKNA Stock | USD 1.53 0.14 8.38% |
If you're considering investing in Ikena Stock, it is important to understand the factors that can impact its price. As of today, the current price of Ikena Oncology stands at 1.53, as last reported on the 26th of December, with the highest price reaching 1.71 and the lowest price hitting 1.51 during the day. Ikena Oncology holds Efficiency (Sharpe) Ratio of -0.0853, which attests that the entity had a -0.0853% return per unit of risk over the last 3 months. Ikena Oncology exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Ikena Oncology's Market Risk Adjusted Performance of (0.30), standard deviation of 1.99, and Risk Adjusted Performance of (0.05) to validate the risk estimate we provide.
Ikena Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Ikena |
Sharpe Ratio = -0.0853
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | IKNA |
Estimated Market Risk
| 2.01 actual daily | 17 83% of assets are more volatile |
Expected Return
| -0.17 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Ikena Oncology is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ikena Oncology by adding Ikena Oncology to a well-diversified portfolio.
Price Book 0.5501 | Enterprise Value Ebitda (0.54) | Price Sales 112.0408 | Shares Float 13.9 M | Wall Street Target Price 3 |
Ikena Oncology Main Headline on 29th of May 2024
Wedbush downgrades Ikena, cites discontinuation of lead asse... by seekingalpha.com
Wedbush has downgraded Ikena Oncology to neutral, citing Tuesdays announcement that the company was discontinuing development of its lead asset, IK-930. Read more here.
Ikena Oncology Valuation on May 29, 2024
It is possible to determine the worth of Ikena Oncology on a given historical date. On May 29, 2024 Ikena was worth 1.56 at the beginning of the trading date compared to the closed value of 1.67. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Ikena Oncology stock. Still, in general, we apply an absolute valuation method to find Ikena Oncology's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Ikena Oncology where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Ikena Oncology's related companies.
| Open | High | Low | Close | Volume | |
| 1.34 | 1.38 | 1.28 | 1.33 | 1,530,787 | |
05/29/2024 | 1.56 | 1.68 | 1.52 | 1.67 | 3,411,660 |
| 1.70 | 1.85 | 1.70 | 1.79 | 999,805 |
| Backtest Ikena Oncology | | | Ikena Oncology History | | | Ikena Oncology Valuation | Previous | Next |
Ikena Oncology Trading Date Momentum on May 29, 2024
| On May 30 2024 Ikena Oncology was traded for 1.79 at the closing time. The top price for the day was 1.85 and the lowest listed price was 1.70 . The trading volume for the day was 999.8 K. The trading history from May 30, 2024 was a factor to the next trading day price jump. The trading delta at closing time against the next closing price was 7.19% . The trading delta at closing time against the current closing price is 4.79% . |
Ikena Oncology Fundamentals Correlations and Trends
By evaluating Ikena Oncology's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Ikena Oncology's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Ikena financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Ikena Oncology Stock history
Ikena Oncology investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Ikena is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Ikena Oncology will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Ikena Oncology stock prices may prove useful in developing a viable investing in Ikena Oncology
Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. The company was incorporated in 2016 and is headquartered in Boston, Massachusetts. Ikena Oncology operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 79 people.
Ikena Oncology Quarterly Net Working Capital |
|
Ikena Oncology Stock Technical Analysis
Ikena Oncology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Ikena Oncology Period Price Range
Low | December 26, 2024
| High |
0.00 | 0.00 |
Ikena Oncology cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Ikena Oncology December 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Ikena Oncology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ikena Oncology shares will generate the highest return on investment. By undertsting and applying Ikena Oncology stock market strength indicators, traders can identify Ikena Oncology entry and exit signals to maximize returns
Ikena Oncology Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Ikena Oncology's price direction in advance. Along with the technical and fundamental analysis of Ikena Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Ikena to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.16) | |||
| Total Risk Alpha | (0.23) | |||
| Treynor Ratio | (0.31) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Ikena Stock analysis
When running Ikena Oncology's price analysis, check to measure Ikena Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ikena Oncology is operating at the current time. Most of Ikena Oncology's value examination focuses on studying past and present price action to predict the probability of Ikena Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ikena Oncology's price. Additionally, you may evaluate how the addition of Ikena Oncology to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |